Search Results - "MORGENSTERN, G"

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue by Wardley, A.M., Jayson, G.C., Swindell, R., Morgenstern, G.R., Chang, J., Bloor, R., Fraser, C.J., Scarffe, J.H.

“…Four hundred and twenty‐nine patients received myeloablative chemotherapy for solid and haematological malignancies in a bone marrow transplantation unit…”
Get full text

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse by Tobal, K., Newton, J., Macheta, M., Chang, J., Morgenstern, G., Evans, P. A.S., Morgan, G., Lucas, G.S., Yin, J. A. Liu

“…One of the most common translocations in acute myeloid leukemia (AML) is the t(8;21), which produces the fusion gene AML1-MTG8. We have developed a sensitive…”
Get full text

Peripheral Blood Progenitor Cell Transplantation in Lymphoma and Leukemia Using a Single Apheresis by Pettengell, R., Morgenstern, G.R., Woll, P.J., Chang, J., Rowlands, M., Young, R., Radford, J.A., Scarffe, J.H., Testa, N.G., Crowther, D.

“…Myeloablative treatment and peripheral blood progenitor cell (PBPC) transplantation are increasingly used for lymphomas and leukemias. We have sought to…”
Get full text

PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients by Jones, M E, Fox, A J, Barnes, A J, Oppenheim, B A, Balagopal, P, Morgenstern, G R, Scarffe, J H

“…AIM: To evaluate a newly developed aspergillus mitochondrial gene PCR-ELISA assay for the early diagnosis of invasive pulmonary aspergillosis (IPA) in…”
Get full text

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity by Decatris, M. P., Wilkinson, P. M., Welch, R. S., Metzner, M., Morgenstern, G. R., Dougall, M.

“…Background: The prognosis of patients with high-risk germ-cell cancer is poor. The toxicity and efficacy of first-line high-dose chemotherapy (HDCT) with…”
Get full text

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma by Pettengell, R, Radford, J A, Morgenstern, G R, Scarffe, J H, Harris, M, Woll, P J, Deakin, D P, Ryder, D, Wilkinson, P M, Crowther, D

“…To compare standard and intensive treatment strategies for patients with high-grade non-Hodgkin's lymphoma (NHL) of poor prognosis, defined by the…”
Get more information

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost by LEE, S. M, RADFORD, J. A, DOBSON, L, HUQ, T, RYDER, W. D. J, PETTENGELL, R, MORGENSTERN, G. R, SCARFFE, J. H, CROWTHER, D

“…In order to evaluate the potential clinical and economic benefits of granulocyte colony-stimulating factor (G-CSF, filgrastim) following peripheral blood…”
Get full text

Radially non-uniform interaction of nitrogen with silicon wafers by Akhmetov, V., Kissinger, G., Fischer, A., Morgenstern, G., Ritter, G., Kittler, M.

“…Reproducible and pronounced ring-like structures have been revealed on both sides of commercial grade wafers after certain regimes of annealing in pure…”
Get full text

VAD chemotherapy as remission induction for multiple myeloma by ANDERSON, H, SCARFFE, J. H, YOUNG, R, WIERINGA, G. S, MORGENSTERN, G. R, FITZSIMMONS, L, RYDER, D

“…A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or…”
Get full text

Performing bone marrow biopsies with or without sedation: a comparison by Giannoutsos, I., Grech, H., Maboreke, T., Morgenstern, G.

“…Summary Although intravenous sedation (ISED) in addition to a local anaesthetic (LA) is commonly used in the performance of a bone marrow aspirate and trephine…”
Get full text

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies by Morgenstern, Godfrey R., Prentice, Archibald G., Grant Prentice, H., Ropner, Janet E., Schey, Stephen A., Warnock, David W.

“…Fluconazole is widely used as antifungal prophylaxis but it is ineffective against Aspergillus. Itraconazole has a broader spectrum of activity but the…”
Get full text

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study by Shamash, J., Lee, S. M., Radford, J. A., Rohatiner, A. Z. S., Chang, J., Morgenstern, G. R., Scarffe, J. H., Deakin, D. P., Lister, T. A.

“…Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymphoma (HL) although a significant proportion of patients…”
Get full text

Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit by Chadwick, P.R., Oppenheim, B.A., Fox, A., Woodford, N., Morgenstern, G.R., Scarffe, J.H.

“…The clinical and molecular epidemiology of two clusters of colonization and infection of patients by glycopeptide-resistant enterococci (GRE) on a leukaemia…”
Get full text

Chronic Lyme Disease: It's Not All in Our Heads by Morgenstern, Robert G.

“…Those of us with chronic Lyme disease are not at all confused, as suggested by Sigal and Hassett (2002). We know from years of experience that we have real,…”
Get full text

Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation by KASPER, C, JONES, L, FUJITA, Y, MORGENSTERN, G. R, SCARFFE, J. H, CHANG, J

“…Splenic rupture is a rare but well-recognized complication of hematological malignancies. Here, we present the case of a 22-year-old woman with the diagnosis…”
Get full text

Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies by Malladi, R. K., Peniket, A. J., Norton, A. E., Campbell, A. J., Collins, G. P., Samol, J., Eagleton, H., Miller, E., Morgenstern, G., Jones, J., Keen-Mcguire, A., Barnardo, M., Littlewood, T. J.

“…:  We report the use of reduced‐intensity conditioning (RIC)‐matched sibling allogeneic bone marrow stem cell transplantation as a method of establishing a…”
Get full text

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma by LEE, S, RYDER, W, CLEMONS, M, MORGENSTERN, G, CHANG, J, SCARFFE, J, RADFORD, J

“…The aim of the study was to determine treatment outcome and identify a particularly high risk group in a consecutive series of 66 patients with poor prognosis…”
Get full text

Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma by Scheid, C, Pettengell, R, Ghielmini, M, Radford, J A, Morgenstern, G R, Stern, P L, Crowther, D

“…Chemotherapy induces high remission rates in high-grade lymphoma. However relapse remains a major problem. One approach to this is myeloablative chemotherapy…”
Get more information

Early investigation and initiation of therapy for invasive pulmonary aspergillosis in leukaemic and bone marrow transplant patients by Barnes, Amanda J., Oppenheim, B. A., Chang, J., Morgenstern, G. R., Scarffe, J. H.

“…Invasive fungal infections are an increasingly common problem in cancer patients and in other vulnerable groups. Invasive pulmonary aspergillosis (IPA) in the…”
Get full text

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients by BRONCHUD, M. H, POTTER, M. R, DEXTER, T. M, MORGENSTERN, G, BLASCO, M. J, SCARFFE, J. H, THATCHER, N, CROWTHER, D, SOUZA, L. M, ALTON, N. K, TESTA, N. G

“…Twelve patients with small cell lung cancer were treated with recombinant human granulocyte colony-stimulating factor, rhG-CSF, given by continuous infusion at…”
Get full text